Department of Neurosurgery, Ghent University Hospital, Ghent, Belgium.
Department of Pathology, AZ St Lucas Gent, Gent, Belgium.
Acta Oncol. 2021 May;60(5):613-619. doi: 10.1080/0284186X.2021.1893899. Epub 2021 Mar 9.
The subventricular zone (SVZ) is an important niche for neural stem cells but probably also for brain tumor propagating cells, including the glioblastoma stem cell. The SVZ may become a target for radiation therapy in glioblastoma patients. However, reports studying the effect of irradiation of the SVZ on glioblastoma patient survival show conflicting results. We studied the correlation between incidental SVZ radiation dose and survival in a cohort of -wildtype (IDHwt) glioblastoma patients with inclusion of important survival prognosticators.
In this retrospective analysis, only adult patients with supratentorial IDHwt glioblastoma were included who were treated with temozolomide-based chemoradiotherapy after surgery. The SVZ was contoured on the radiotherapy planning imaging. Cox proportional regression overall survival (OS) analysis was used to study the correlation between SVZ dose and survival. Age, Karnofsky Performance Score, extent of resection and gene promoter (MGMTp) methylation were used as covariates in multivariate analysis.
In total, 137 patients were included. Median OS was 13.3 months. The MGMTp methylation was present in 40% of cases. Ipsilateral SVZ (iSVZ) mean dose was 44.4 Gy and 27.2 Gy for the contralateral SVZ (cSVZ). Univariate survival analysis showed an inverse relationship between cSVZ mean dose and OS (HR 1.029 (1.003-1.057); = .032). However, there was no correlation between cSVZ mean dose and OS in multivariate analysis. iSVZ dose did not correlate with survival.
In this cohort of 137 IDHwt glioblastoma patients, iSVZ did not correlate with OS. Higher cSVZ dose was inversely correlated with OS in univariate survival analysis but lost its significance in multivariate analysis, including MGMTp-methylation. Hence, the correlation between SVZ radiation and glioblastoma patient survival remains unclear. Carefully designed prospective studies are needed to provide unequivocal results on this controversial topic.
侧脑室下区(SVZ)是神经干细胞的重要龛位,但也可能是脑肿瘤增殖细胞的龛位,包括胶质母细胞瘤干细胞。SVZ 可能成为胶质母细胞瘤患者放射治疗的靶点。然而,研究 SVZ 照射对胶质母细胞瘤患者生存影响的报告结果相互矛盾。我们研究了包含重要生存预后因素的野生型(IDHwt)胶质母细胞瘤患者队列中 SVZ 照射剂量与生存的相关性。
在这项回顾性分析中,仅纳入接受手术切除后接受替莫唑胺为基础的放化疗的幕上 IDHwt 胶质母细胞瘤成年患者。在放射治疗计划图像上勾画 SVZ。使用 Cox 比例风险回归总体生存(OS)分析来研究 SVZ 剂量与生存之间的相关性。年龄、卡诺夫斯基表现评分、切除范围和基因启动子(MGMTp)甲基化作为多变量分析的协变量。
共纳入 137 例患者。中位 OS 为 13.3 个月。MGMTp 甲基化存在于 40%的病例中。同侧 SVZ(iSVZ)平均剂量为 44.4Gy,对侧 SVZ(cSVZ)平均剂量为 27.2Gy。单变量生存分析显示 cSVZ 平均剂量与 OS 呈负相关(HR 1.029(1.003-1.057);=0.032)。然而,在多变量分析中,cSVZ 平均剂量与 OS 无相关性。iSVZ 剂量与生存无关。
在本队列的 137 例 IDHwt 胶质母细胞瘤患者中,iSVZ 与 OS 无相关性。在单变量生存分析中,较高的 cSVZ 剂量与 OS 呈负相关,但在包括 MGMTp 甲基化在内的多变量分析中失去了意义。因此,SVZ 照射与胶质母细胞瘤患者生存之间的相关性仍不清楚。需要精心设计的前瞻性研究来提供这个有争议话题的明确结果。